Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Cash from Investing Activities (2021 - 2025)

Neuroone Medical Technologies' Cash from Investing Activities history spans 5 years, with the latest figure at -$40754.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 66.92% year-over-year to -$40754.0; the TTM value through Dec 2025 reached -$98080.0, up 8.75%, while the annual FY2025 figure was -$81742.0, 31.99% up from the prior year.
  • Cash from Investing Activities reached -$40754.0 in Q4 2025 per NMTC's latest filing, down from -$10607.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.8 million in Q1 2023 to a low of -$3.0 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$45228.6, with a median of -$33234.5 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: tumbled 8546.56% in 2022, then soared 2054.91% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$61491.0 in 2021, then surged by 124.51% to $15069.0 in 2022, then tumbled by 346.41% to -$37131.0 in 2023, then skyrocketed by 34.24% to -$24416.0 in 2024, then crashed by 66.92% to -$40754.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Cash from Investing Activities are -$40754.0 (Q4 2025), -$10607.0 (Q3 2025), and -$43548.0 (Q2 2025).